Treatment burden following perioperative care encompasses the cumulative physical, psychological, and logistical demands placed on patients as they recover from surgical interventions. This review synthesizes current evidence on epidemiology, pathophysiology, risk factors, clinical manifestations, diagnostic approaches, management strategies, and emerging therapies related to treatment burden post-surgery. The article aims to provide an in-depth understanding for clinicians to minimize unnecessary burden, optimize patient outcomes, and align care with recent clinical guidelines and patient-centered best practices.
\nThe concept of treatment burden has gained increasing recognition in perioperative medicine, reflecting the multi-dimensional impact of healthcare interventions on patients' quality of life and recovery trajectory. Unlike traditional measures focused solely on clinical outcomes, treatment burden emphasizes the totality of tasks patients must perform, including medication management, self-monitoring, follow-up appointments, and lifestyle modifications. In the perioperative context, these demands can significantly influence recovery, adherence, and long-term health status, making it vital for healthcare professionals to understand and address treatment burden in the continuum of surgical care.
\nRecent studies indicate that a substantial proportion of post-surgical patients experience moderate to high levels of treatment burden. In a multicenter cohort study, up to 40% of elective surgery patients reported difficulties managing prescribed regimens and follow-up care. Older adults, those with comorbidities, and socioeconomically disadvantaged populations are disproportionately affected. Treatment burden has been associated with poorer health-related quality of life, increased hospital readmissions, and decreased adherence to recommended therapies. These data underscore the need for targeted interventions to reduce burden and promote equitable recovery outcomes across diverse surgical populations.
\nTreatment burden arises from a dynamic interplay between the intensity of prescribed healthcare regimens and the individual’s capacity to manage these demands. Mechanistically, perioperative care often involves polypharmacy, complex wound care, physical rehabilitation, and adherence to preventive measures, each of which can tax cognitive, emotional, and physical resources. The stress response to surgery, compounded by acute pain, sleep disruption, and functional limitation, further exacerbates patients\' vulnerability to treatment burden. Neuropsychological factors, including postoperative delirium and cognitive dysfunction, may impair self-management, while systemic factors such as fragmented care and inadequate discharge planning amplify the burden.
\nSeveral patient- and system-level risk factors increase susceptibility to treatment burden postoperatively. Advanced age, cognitive impairment, low health literacy, limited social support, and preexisting multimorbidity have consistently been identified in observational studies. Surgical factors—such as longer operative times, major procedures, and higher complication rates—also contribute. Health system factors, including poor care coordination, lack of clear discharge instructions, and limited access to rehabilitation resources, further elevate the risk. Recognizing these risk factors enables clinicians to stratify patients and implement individualized mitigation strategies.
\nClinically, treatment burden manifests as nonadherence to medications, missed appointments, incomplete wound care, emotional distress, and reduced engagement in recovery activities. Patients may report feeling overwhelmed, fatigued, or inadequately prepared for self-care tasks. Such manifestations can be subtle yet have profound implications for postoperative recovery, leading to complications such as infection, delayed wound healing, and unplanned readmissions. Assessment tools like the Treatment Burden Questionnaire (TBQ) and the Patient Experience of Treatment Burden scale can facilitate systematic evaluation of these features in routine care.
\nDiagnosis of treatment burden postoperatively involves both subjective and objective assessment methods. Structured interviews and validated questionnaires provide insights into patients\' perceived workload, barriers, and coping strategies. Clinicians should proactively inquire about difficulties with medication regimens, wound care, dietary modifications, and follow-up compliance. Objective indicators, such as missed doses or appointments, serve as red flags. Early identification—ideally beginning in the preoperative phase—enables timely intervention and personalized care planning.
\nEffective management of treatment burden after surgery requires a multidisciplinary, patient-centered approach. Key strategies include simplifying therapeutic regimens, providing clear and accessible education materials, utilizing medication reconciliation, and leveraging technology for remote monitoring and reminders. Involving family members or caregivers in care planning can enhance adherence and support. Transitional care models, where nurse navigators or case managers coordinate post-discharge care, have demonstrated reductions in readmissions and improved patient satisfaction. Tailoring interventions to individual capacity and preferences is essential for optimizing outcomes.
\nRecent advances in digital health offer promising avenues to mitigate treatment burden. Mobile health applications, telemedicine follow-ups, and automated medication reminders are being increasingly integrated into perioperative care pathways. Early clinical trials suggest that such tools can enhance patient engagement, reduce errors, and facilitate real-time communication with healthcare teams. Additionally, minimally invasive surgical techniques and enhanced recovery after surgery (ERAS) protocols, which emphasize multimodal analgesia and early mobilization, have been shown to reduce both physical and psychological burden, supporting faster and more comfortable recoveries.
\nMajor surgical and perioperative care guidelines now recommend routine assessment of treatment burden as part of holistic recovery planning. The American College of Surgeons and the European Society of Anaesthesiology advocate for comprehensive discharge education, streamlined prescribing practices, and formalized transitions of care. Interprofessional collaboration—including pharmacists, nurses, social workers, and primary care providers—is emphasized to ensure continuity and minimize unnecessary complexity. Incorporating patient-reported outcome measures (PROMs) is also encouraged to monitor burden longitudinally and adjust care dynamically.
\nTreatment burden after perioperative care is a multifaceted challenge with significant implications for patient outcomes, adherence, and healthcare utilization. Understanding its epidemiology, pathophysiology, and risk factors enables clinicians to identify at-risk individuals and implement tailored, evidence-based interventions. Recent innovations in digital health and enhanced recovery protocols, coupled with guideline-directed multidisciplinary strategies, offer practical pathways to reduce burden and foster patient-centered recovery. Ongoing research and integration of patient perspectives will be crucial in refining these approaches and achieving optimal perioperative outcomes.
1.
"Unusual" Cancers Following Pandemic; Triumph in TNBC; Clinical Trial Interrupted by Shortage.
2.
Recently released national data on drug use and abuse among Americans.
3.
Despite Medicare Coverage, Cancer Genomic Testing Still Low
4.
Ketamine plus psychotherapy for "excellent" PTSD
5.
Psychedelic Therapy Tied to Reduced Depression, Anxiety.
1.
Personalized Tumor Ecological Landscapes in Oncology
2.
Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer
3.
Preserving Social Identity During Cancer Survivorship
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Regenerative Models of Tumor Microenvironments: Clinical Relevance and Emerging Insights
1.
International Conference on Cancer Nursing and Rehabilitation Strategies
2.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
3.
International Conference on Innovations in Critical Care for Oncology and Cardiology
4.
International Symposium on Oncology, Cardiology and Critical Care Innovations
5.
International Conference on Cancer Nursing and Hematology Support
1.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
4.
From Guidelines to Practice: Hematology
5.
Breast Cancer Awareness and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation